SBI Healthcare Opportunities Fund-Growth
Equity
Sectoral-Pharma
₹-1.2% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
5 - Minimum Investment₹5000
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹5797 Cr
- Created on1 July 1999
Fund Ranking
#3
/ 17 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month21.8%
- 1 Year17.6%
- 3 Year (CAGR)21.6%
- All Time (CAGR)16.5%
Category Return
- 6 Month18.4%
- 1 Year13.5%
- 3 Year (CAGR)20.1%
- All Time (CAGR)16.9%
Asset Allocation
- Equity96.8%
- Debt0.1%
- Other3.2%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise4.91%
- Aurobindo Pharma3.90%
- Cipla4.67%
- Abbott India0.35%
- Poly Medicure1.94%
Fund Information
- Expense Ratio1.98%
- Exit LoadExit load of 0.50% if redeemed within 15 days
- Lock-In PeriodNo Lock-In
Managed By
Tanmaya Desai
June 2011 - Present
Pradeep Kesavan
Dec 2023 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 1.03 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 14.76 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. 2.04 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.87